Experiment 684301
Compounds isolated
Details
| Property | Value |
|---|---|
| Pharmacology | |
| Administration route | IV |
| Organism | Empty organism |
| Citation | MADDEN,T: TRAN,HT: BECK,D: HUIE,R: NEWMAN,RA: PUSZSTAI,L: WRIGHT,JJ: ABBRUZZESE,JL:. (2000). NOVEL MARINE-DERIVED ANTICANCER AGENTS: A PHASE I CLINICAL, PHARMACOLGICAL, AND PHARMACODYNAMIC STUDY OF DOLASTATIN 10 (NSC 3761280 IN PATIENTS WITH ADVANCED SOLID TUMORS.. 6(4) |
| Amount utilized | |
| Compound isolated | |
| Disease | THE MEDIAN AGE FOR ALL PATIENTS WAS 56 YEARS. ALL HAD ADVANCED SOLID TUMORS OF DIFFERENT HISTOLOGICAL TYPE, INCLUDING FOR PATIENTS WITH SARCOMA AND TWO PATIENT WITH MELANOMA. TWENTY-TWO PATIENTS WERE ENROLLED, INCLUDING 10 MALE AND 12 FEMALE. |
| Dose amount | 0.2 MG |
| Number | 1 |
| Qualitative result | ACTIVE |
| Animal | HUMAN ADULT |
| Per unit | ML |
| Dose expression | DOSE |